AGP Picks View all

Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

Press releases published on July 13, 2026

Omnix Medical Launches New Horizon Europe PEPTAMR Infectious Disease Consortium
TolerogenixX Has Received EMA Orphan Drug Designation for MIC-Lx, Strengthening its Regulatory Pathway in Kidney Transplantation
Oxford Brain Diagnostics Advances Vision for Measuring Brain Health and Neurodegenerative Disease with Five New Studies at AAIC 2026
FDH Aero to Showcase Global Expansion and Enhanced Supply Chain Solutions at the 2026 Farnborough International Airshow
Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases
Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases
NAMIB, the New Electronic Warfare Payload Successfully Completes a Collaborative Flight with a Rafale
NAMIB, le nouveau produit de guerre électronique embarqué développé par Harmattan AI et Dassault Aviation, réalise un vol collaboratif avec un Rafale
BALG Report: Bicycle Hit-and-Run Accidents Reach Record High Across US
SCENESSE® approved for EPP in Canada
Santhera erweitert Vereinbarung mit Biomedica zur Ausweitung des Vertriebs von AGAMREE® (Vamorolon) in Zentralasien und im Kaukasus
Santhera Expands Biomedica Agreement to Extend AGAMREE® (Vamorolone) Distribution Across Central Asia and the Caucasus
Palomino Laboratories Common Stock Commences Trading on the OTCQB VENTURE MARKET
New Crypto: AlphaPepe Presale Solidifies AI DEX Rollout As XRP Price Prediction Eyes Next Shiba Inu Move

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today in Science

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.